Work

MDS-515: Durable Complete Remission Following HMA Therapy in Higher-Risk MDS Is Not Fully Determined by Baseline Disease Biology

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)02225-1

Authors: Julie Braish, Najla Al Ali, Zena Komrokji RA, Zhuoer Xie, Onyee Chan, Andrew T Kuykendall, Seongseok Yun, Rory M Shallis, Sam B Reynolds, Alison R Walker, Jeffrey E Lancet, Eric Padron, David A Sallman, Rami S Komrokji

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204733838

Cites:

Cited by:

Related to: 10